首页> 外文期刊>Eye Science >Evidence-based Management of Glaucoma
【24h】

Evidence-based Management of Glaucoma

机译:青光眼的循证管理

获取原文
获取原文并翻译 | 示例
       

摘要

Purpose: The evidence-based medicine (EBM) is a new medical mode that is completely different from traditional experience-based medicine. The core of EBM is that decision-making during clinical practices must be based on objective research results. With the rapid development of modern ophthalmology, some former viewpoints according to experience-based medicine face challenges. Evidence-based ophthalmology (EBO) is imperative under the situation. Glaucoma, as a disease resulting in blindness, which can not be cured by operation, is thought more and more of by medical management officials and doctors. One challenge for ophthalmologists entering the 21st century will be to make clinical decisions based on valid information or evidence rather than intuition, hearsay, or peer practice. How can we do? Here reviews the application of EBM in medical management of glaucoma since EBM's naissance and give a reference.
机译:目的:循证医学(EBM)是一种新的医学模式,与传统的基于经验的医学完全不同。 EBM的核心在于临床实践中的决策必须基于客观的研究结果。随着现代眼科学的飞速发展,一些以往基于经验医学的观点面临挑战。在这种情况下,循证眼科(EBO)势在必行。青光眼是导致失明的疾病,无法通过手术治愈,越来越多的医疗管理人员和医生认为青光眼是一种疾病。进入21世纪,眼科医生面临的挑战之一是根据有效的信息或证据做出临床决策,而不是凭直觉,传闻或同行惯例做出决策。我们该怎么办?本文综述了自循证医学诞生以来,循证医学在青光眼医疗管理中的应用,并提供参考。

著录项

  • 来源
    《Eye Science》 |2005年第1期|p.20-26|共7页
  • 作者

    Yangfan Yang; Minbin Yu;

  • 作者单位

    Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 510060, China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 R7;
  • 关键词

    evidence-based medicine; glaucoma;

    机译:循证医学;青光眼;
  • 入库时间 2022-08-18 00:50:49

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号